Skip to main content
. 2017 Mar 24;22(5):592–600. doi: 10.1634/theoncologist.2016-0308

Table 1. Baseline patient characteristics.

image

a

These drugs were administered as a single‐rescue use only.

Abbreviations: Bmab, bevacizumab; CapeOX, capecitabine (Cape)/oxaliplatin (OX); CDDP, cisplatin; Cmab, cetuximab; DTX, docetaxel; E, erlotinib; ECOG PS, Eastern Cooperative Oncology Group performance status; FL, 5‐fluorouracil (5FU)/leucovorin (LV); FOLFIRI, 5FU/LV/irinotecan(IRI); FOLFIRINOX, 5FU/LV/OX/IRI; FOLFOX, 5FU/LV/OX; GC, glucocorticoid; Gem, gemcitabine; nabPTX, nanoparticle albumin‐bound paclitaxel (PTX); Pmab, panitumumab; SOX, S‐1/OX; Tmab, trastuzumab.